Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system

Reviews in the Neurosciences

Volumn 9, Issue 2, 1998, Pages 105-116

  Keller, Jeffery N ^a,b   Mattson, Mark P ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apoptosis; D hydroxynonenal; Lipid peroxidation; Neuron; Oxyradicals; Transporters

Indexed keywords

4 HYDROXYNONENAL; FREE RADICAL; HYDROXYL GROUP; MALONALDEHYDE; PEROXYNITRITE; POLYUNSATURATED FATTY ACID;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL DEATH; CYTOTOXICITY; ISCHEMIA; LIPID PEROXIDATION; LONG TERM POTENTIATION; NEURITE; NEUROPATHOLOGY; NEUROTOXICITY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0031840571     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.1998.9.2.105     Document Type: Review

References (100)

1. Ames BN, Shingenaga MK, Hagan TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-7922.
2. Ankarcrona M, Dybukt JM, Bonfoco E, Zhivosky B, Orrenius S, Lipton SA, Nicotera P. Glutamate induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995; 15: 961-973.
3. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1994; 19: 357-366.
4. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994; 77: 817-827.
5. Benedetti A, Fulceri R, Comporti M. Inhibition of calcium sequestration activity of liver microsomes by 4-hydroxynonenals origionating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 1984; 793: 489-493.
6. Benedetti A, Comporti M. Formation, reactions and toxicity of aldehydes produced in the course of lipid peroxidation in cellular membranes. Bioelectrochem Bioenerget 1987; 18: 187-202.
7. Benzi G, Moretti A. Age and peroxidative stress related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Rad Biol Med 1995; 19: 77-101.
8. Blanc EM, Keller JN, Fernandez S, Mattson MP. 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 1997; 15: 1-12.
9. Blanc EM, Bruce-Keller AJ, Mattson MP. Astrocytic gap junctional communication decreases vulnerability to oxidative stress induced disruption of calcium homeostasis and cell death. J Neurochem 1998; in press.
10. Blanc EM, Kelly JF, Mark RJ, Waeg G, Mattson MP. 4-Hydroxynenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action G alpha (q/11). J Neurochem 1997; 69: 570-580.
11. Bolkenius FN, Monard D. Inactivation of pr̈otease nexin-1 by xanthine oxidase derived free radicals. Neurochem Int 1995; 26: 587-592.
12. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. Biochem J 1984; 134: 707-716.
13. Boveris A, Cadenas E, Stoppani AOM. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J 1976; 156: 435-444.
14. Bruce-Keller AJ, Li YJ, Lovell MA, Kraemer PJ, Gary DS, Brown RR, Markesberry WR, Mattson MP. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholenergic neurons and impairs visuospatial memory in rats. J Neuropath Exp Neurol 1998; in press.
15. Camandola S, Scavazza A, Leonarduzzi G, Biasi F, Chiarpotto E, Azzi A, Poli G. Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-kappa B in cells of the macrophage lineage. Biofactors 1997; 6: 173-179.
16. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695.
17. Czubryt MP, Panagia V, Pierce GN. The roles of free radicals, peroxides and oxidized lipoproteins in second messenger system dysfunction. In: Karmazyn M, ed. Myocardial Ischemia: Mechanism, Reperfusion, Protection. Basel: Birkhauser Verlag, 1986.
18. Cross AR, Jones OTG. Enzymatic mechanisms of superoxide generation. Biochim Biophys Acta 1991; 1057: 281-298.
19. Davis DW, Hamilton RF, Holian A. 4-Hydroxynonenal inhibits interleukin-1 beta converting enzyme. J Interferon Cytokine Res 1997; 17: 205-210.
20. Dypbukt JM, Ankarcrona M, Burkitt M, Sjoholm A, Strom K, Orrenius S, Nicotera P. Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin secreting RINm5F cells. J Biol Chem 1994; 269: 30553-30560.
21. 2+ in rat liver microsomes. Biochem J 1994; 208: 129-140.
22. Esterbauer H, Zollner H, Lang J. Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver fractions. Biochem J 1985; 228: 363-373.
23. Esterbauer H, Schauer RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 1991; 11: 81-128.
24. Esterbauer H. Cytotoxicity and genotoxicity of lipid peroxidation products. Am J Clin Nutr 1993; 57: 779S-786S.
25. Farooqui AA, Rapoport SI, Horrocks LA. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens. Neurochem Res 1997; 22: 523-527.
26. Fench CE, Tanzi RE. Genetics of aging. Science 1997; 278: 407-411.
27. Frankel EN. Volatile lipid peroxidation products. Prog Lipid Res 1982; 22: 1-33.
28. Friguet B, Szweda LI. Inhibition of multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross linked protein. FEBS Lett 1997; 405: 11-15.
29. Fukuda A, Nakamura Y, Ohigashi H, Osawa T, Uchida K. Cellular response to the redox active lipid peroxidation products: induction of glutathione S-transferase P by 4-hydroxy-2-nonenal. Biochem Biophys Res Comm 1997; 236: 505-509.
30. Gerlach M, Riederer P, Youdim MBH. Molecular mechanisms for neurodegeneration: synergism between reactive oxygen species, calcium, and excitatory amino acids. Adv Neurol 1996; 69: 177-194.
31. Gunter TE, Gunter KK, Sheu SS, Gavin CE. Mitochondrial calcium transport: physiological and pathological relevance. Am J Physiol 1994; 267: C313-C339.
32. Grune T, Siems WG, Zollner H, Esterbauer H. Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product in Ehrlich mouse ascites cells at different proliferation stages. Cancer Res 1994; 54: 5231-5235.
33. Hammer A, Ferro M, Tillian HM, Zollner H, Schauenstein E, Schaur RJ. Effect of oxidative stress by iron on 4-hydroxynonenal formation and proliferative activity in hepatomas of different degrees of differentiation. Free Rad Biol Med 1997; 23: 26-33.
34. Haenen GRMM, Jacintha NL, Tsoi TT, Vermeulen NPE, Timmerman H, Bast A. 4-Hydroxy-2,3-transnonenal stimulates microsomal lipid peroxidation by reducing the glutathione dependent protection. Arch Biochem Biophys 1987; 259: 449-456.
35. Halliwell B, Gutteridge, JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501-514.
36. Halliwell B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine. Oxford: Clarendon Press, 1989.
37. Hockenberry DM, Zoltan NO, Yin XM, Milliman CL, Korsemeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251.
38. Hochstrasser M. Ubiquitin-dependent protein degredation. Ann Rev Genet 1996; 30: 405-439.
39. Jacob RA, Burri BJ. Oxidative damage and defense. Am J Clin Nutr 1996; 63: 985S-990S.
40. Jurgens G, Lang J, Esterbauer H. Modifications of human low density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim Biophys Acta 1986; 875: 103-114.
41. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, Mattson MP. Impairement of glucose and glutamate transport, and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997; 69: 273-284.
42. Keller JN, Steiner MR, Holtsberg FW, Mattson MP, Steiner SM. Lysophosphatidic acid induced proliferation related signals in astrocytes. J Neurochem 1997; 69: 1073-1084.
43. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Hutchins JB, Mattson MP. Mn-SOD prevents neural apoptosis by suppressing peroxynitrite production and consequent lipid peroxidation and mitochondrial dysfunction, and reduces ischemic brain injury in vivo. J Neurosci 1998; 18: 687-697.
44. Kristal BS, Park BK, Yu BP. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J Biol Chem 1997; 271: 6033-6038.
45. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997; 18: 44-51.
46. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 1997; 17: 5089-5100.
47. Kuo CL, Vaz AD, Coon MJ. Metabolic activation of trans-4-hydroxy-2-nonenal, a toxic product of membrane lipid peroxidation and inhibitor of P450 cytochromes. J Biol Chem 1997; 272: 22611-22616.
48. Lander HM. An essential role for free radicals and derrived species in signal transduction. FASEB J 1997; 11: 118-124.
49. Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G. The lipid peroxidation product 4-hydroxy-2,3-nonenal up regulates transforming growth factor beta 1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 1997; 11: 851-857.
50. Licinio J. Central nervous system cytokines and their relevance for neurotoxicity and apoptosis. J Neural Transm 1997; 49 (Suppl): 169-175.
51. Lopez O, Bonnefont-Rousselot D, Mollereau M, Olivier R, Montagnier L, Emerit J, Delattre J. Increased plasma thiobarbituric acid reactive substances (TBARS) before opportunistic infection symptoms in HIV infected individuals. Clin Chim Acta 1996; 247: 181-187.
52. Lovell MA, Ehmann WD, Markesbery WR. Elevated 4-hydroxynonenal in Alzheimer's disease. Ann Neurol (in press).
53. Luo Y, Bond JD, Ingram VM. Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. Proc Natl Acad Sci USA 1997; 94: 9705-9710.
54. Marchetti P, Decaudin D, Macho A, Zamzami N, Hirsch T, Susin SA, Kroemer G. Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. Eur J Immunol 1997; 27: 289-296.
55. Mark RJ, Hensley K, Butterfield DA, Mattson MP. Amyloid β-peptide impaires ion-motive ATPase activities: evidence for a role in loss of neuronal calcium homeostasis and cell death. J Neurosci 1997; 15: 6239-6249.
56. Mark RJ, Lovell MA, Markesberry WA, Uchida K, Mattson MP. A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 1997; 68: 255-264.
57. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid beta peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 1997; 17: 1046-1054.
58. Markesberry WR. Oxidative stress hypothesis in Alzheimer's disease. Free Rad Biol Med 1997; 23: 134-147.
59. Marnett LJ, Hurd HK, Hollstein MC, Levin DE, Esterbauer H, Ames BN. Naturally occuring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mut Res 1985; 148: 25-34.
60. Massa SM, Swanson RA, Sharp FR. The stress gene response in brain. Cereb Brain Rev 1996; 8: 95-158.
61. Masliah E, Ge N, Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit Rev Neurobiol 1996; 10: 57-67.
62. Mattson MP. Calcium and neuronal injury in Alzheimer's disease: contributions of β-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann NY Acad Sci 1994; 747: 50-76.
63. Mattson MP. Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease. TINS 1997; 20: 373-375.
64. Mattson MP. Modification of ion homeostasis by lipid peroxidation: roles in neural degeneration and adaptive plasticity. TINS 1998; 21: 1-9.
65. Mattson MP, Barger SW, Begley JG, Mark RJ. Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. In: Tanzi R, ed. Molecular Mechanisms of Dementia. Newark, NJ: Humana Press, 1996; 103-143.
66. Mattson MP, Fu W, Waeg G, Uchida K. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule associated protein tau. NeuroReport 1997; 8: 2275-2281.
67. Mattson MP, Guo Q, Furukawa K, Pederson WA. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 1998; 70: 1-14.
68. Montine KS, Olson SJ, Amarnath V, Whetsell WO, Graham DG, Montine TJ. Immunohistochemical localization of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is assocaited with inheritance of APOE4. Am J Pathol 1997; 150: 437-443.
69. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan SF, Chan PH. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 1998; 18: 205-213.
70. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci USA 1996; 93: 9893-9898.
71. Natarajan V, Scribner WM, Vepa S. Phosphatase inhibitors potentiate 4-hydroxynonenal induced phospholipase D activation in vascular endothelial cells. Am J Resper Cell Mol Biol 1997; 17: 251-259.
72. Nishikawa A, Sodum R, Chung FL. Acute toxixity of trans-5-hydroxy-2-nonenal in Fischer 344 rats. Lipids 1992; 27: 54-58.
73. Nourooz-Zadeh J, Rahimi A, Tajaddini MJ, Tritscler H, Rosen P, Halliwell B, Betteridge DJ. Relationship between plasma measures of oxidative stress and metabolic control of NIDDM. Diabetologia 1997; 40: 647-653.
74. Papa S, Skulachev VP. Reactive oxygen species, mitochondria, apoptosis, and aging. Mol Cell Biochem 1997; 174: 305-319.
75. Pryor WA, Porter NA. Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Rad Biol Med 1990; 8: 541-543.
76. 2+ permeability. Biochem Biophys Res Comm 1997; 235: 451-454.
77. Reed JC. Cytochrome c: can't live with it - can't live without it. Cell 1997; 91: 559-562.
78. Romero FJ, Romero MJ, Bosch-Morell F, Martinez MC, Median P, Lluch S. 4-Hydroxynonenal induced relaxation of human mesenteric arteries. Free Rad Biol Med 1997; 23: 521-523.
79. Rossi MA, Fidale F, Garramone A, Esterbauer H, Dianzani MU. Effect of 4-hydroxynonenals on hepatic phosphoinositol-4,5-bis-phosphate-phospholipase C. Biochem Pharmacol 1990; 39: 1715-1719.
80. Rothwell NJ. Cytokines and acute neurodegeneration. Mol Psychiatry 1997; 2: 120-121.
81. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997; 91: 443-446.
82. Sayer LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4-Hydroxynonenal derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neuropath Exp Neurol 1997; 56: 866-871.
83. Sies H. Biochemistry of oxidative stress. Agnew Chem Int Ed Engl 1986; 25: 1058-1071.
84. Slater AFG, Nobel CSI, Orrenius S. The role of intracellular oxidants in apoptosis. Biochim Biophys Acta 1995; 1271: 59-62.
85. 2 resistant cell lines. Biochem J 1990; 267: 453-459.
86. Spitz DR, Sullivan SJ, Malcolm RR, Roberts RJ. Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Rad Biol Med 1991; 11: 415-423.
87. Springer JE, Azbill RD, Mark RJ, Begley JG, Waeg G, Mattson MP. 4-Hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J Neurochem 1997; 68: 2469-2476.
88. Subramaniam R, Roediger F, Jordan B, Mattson MP, Keller JN, Waeg G, Butterfield DA. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J Neurochem 1997; 69: 1161-1169.
89. Tucker T, Steiner MR, Steiner SM. Inhibition of cardiolipin synthesis following infection with Herpes simplex virus. Intervirology 1974; 4: 249-256.
90. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 1980; 191: 421-427.
91. Uchida K, Toshihiko O, Hiai H, Toyokuni S. 4-Hydroxy-2-nonenal trapping ELISA: direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins. Biochim Biophys Acta 1995; 212: 1068-1073.
92. Ueda K, Kobayashi S, Morita J, Komano T. Site specific DNA damage caused by lipid peroxidation products. Biochim Biophys Acta 1985; 824: 341-348.
93. Van Kuijk FJGM, Holte LL, Dratz EA. 4-Hydroxyhexenal: a lipid peroxidation product derrived from oxidized docosahexaenoic acid. Biochim Biophys Acta 1990; 1043: 116-118.
94. Wells KE, Alexander JJ, Miguel RM. Calcium dependent second messenger regulation of low density lipoprotein oxidation by human aortic smooth muscle. Surgery 1996; 120: 337-344.
95. White RJ, Reynolds IJ. Mitochondrial depolarization in glutamate stimulated neurons: an early signal specific to excitotoxin exposure. J Neurosci 1996; 16: 5688-5697.
96. Xie Z, Sastry BR. Induction of hippocampal long term potentiation by alpha-tocopherol. Brain Res 1993; 602: 173-179.
97. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1987; 45: 337-351.
98. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson's disease. Proc Natl Acad Sci USA 1996; 93: 2696-2701.
99. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182: 367-377.
100. Zhuang FP, Fang ZT, Yang B, Fogelman AM, Berliner JA. Stimulation of Gs and inhibition of Gi protein functions by minimally oxidized LDL. Art Throm Vasc Biol 1995; 15: 2019-2024.